Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The patent claims describe methods for producing IHAT (Iron Hydroxide Adipate Tartrate), where Generally Recognised As Safe (GRAS) organic acids, and particularly Tartaric and Adipic acids, are used to modify the ferrihydrite nanocore of ferritin.
Product Name : IHAT-02
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 05, 2021
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable